Radiotherapy Background

4
Average
4.1
Rating : 12345
Rate This Article : 1 2 3 4 5
RSS Email Print This Page Comment bookmark
Font : A-A+

Latest Publications and Research on Radiotherapy

Nanoscale  2018 Jul 16  

Development of a thermosensitive protein conjugated nanogel for enhanced radio-chemotherapy of cancer.

Maiti D, Chao Y, Dong Z, Yi X, He J, Liu Z, Yang K

Although chemo-radiotherapy has been widely applied in clinics for cancer treatment, current strategies still face many challenges including serious s... Read More

Source: PubMed


Int. J. Clin. Pract.  2018 Jul 16  

Second cancers in Hodgkin's lymphoma long-term survivals: A 60-year single institutional experience with real-life cohort of 871 patients.

Petrakova K, Vyskocil J, Grell P, Majek O, Soumarova R, Novak J, Burkon P, Kral Z, Kazda T, Vyzula R

Appropriate surveillance guidelines for patients after successful treatment of Hodgkin's lymphoma (HL) are needed to reduce mortality of iatrogenic se... Read More

Source: PubMed

J. Radiat. Res.  2018 Jul 12  

The conditioned medium of human mesenchymal stromal cells reduces irradiation-induced damage in cardiac fibroblast cells.

Chen ZY, Hu YY, Hu XF, Cheng LX

Recently, multipotent mesenchymal stromal cell (MSC) treatment has attracted special attention as a new alternative strategy for stimulating regenerat... Read More

Source: PubMed

J. Radiat. Res.  2018 Jul 11  

Comparison of passive and scanning irradiation methods for carbon-ion radiotherapy for breast cancer.

Matsubara H, Karasawa K, Furuichi W, Wakaisami M, Shiba S, Wakatsuki M, Omatsu T, Inaniwa T, Fukuda S, Kamada T

The dose distribution of passive and scanning irradiation for carbon-ion radiotherapy for breast cancer was compared in order to determine the preferr... Read More

Source: PubMed

Ann. Oncol.  2018 Jul 13  

Nintedanib for the treatment of patients with refractory metastatic colorectal cancer (LUME-Colon 1): a phase III, international, randomized, placebo-controlled study.

Van Cutsem E, Yoshino T, Lenz HJ, Lonardi S, Falcone A, Limón ML, Saunders M, Sobrero A, Park YS, Ferreiro R, Hong YS, Tomasek J, Taniguchi H, Ciardiello F, Stoehr J, Oum'Hamed Z, Vlassak S, Studeny M, Argiles G

Angiogenesis is critical to colorectal cancer (CRC) growth and metastasis. Phase I/II studies have demonstrated the efficacy of nintedanib, a triple a... Read More

Source: PubMed

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions
nizamzualiz

There is opinion saying Radiotherapy and Chemotherapy treatment are not actually killing the cancer cells but the cells are kept [or maybe deactivated] for a period of time... It will strike back. At that point of time, we may be able to do the same treatment/s, but the attack usually more severe than the first. Possibly, the patient may have no energy to go through the second episode of treatment (due to age and/or tiredness and/or cost incurred). If you are not lucky, the second cancer will strike due to the treatment itself. So, instead of killing the cancer cells the treatment may create second cancer. Appreciate comments please

faranak

could IMRT done near an organ cause the organ a condition that can not be transplanted if needed?

hi!
can i ask what's the difference between conventional fractionated XRT versus stereotactic radiosurgery vs external beam radiation therapy?

Advertisement

Health Topics A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Medindia Health Topics Search

Cancer

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Doctor Search

Stay Connected

  • Available on the Android Market
  • Available on the App Store